ARCHIVES

Drug Development Committee Demands, Gets Greater Voice In Contract Awards, Review of Unsolicited Proposals, Suggests RFP For New Screening Systems

This article is from The Cancer Letter archive.

Vol. 02 No. 01 | January 2, 1976

Download PDF Visit The Full Archive

Related Articles

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

March 7, 2008

Prostatectomy Lowers Death Risk Compared to Watchful Waiting

April 29, 2011

Funding Opportunities

January 17, 2003

Funding Opportunities: NCI’s RAPID Program; RFA, Pas Avilable

May 14, 1999

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

NCI, American Cancer Society Re-Evaluating Join Guidelines On Mammography Screening

September 17, 1993